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Abstract
Since the identification of mesenchymal stem cells, stem cell biology is a greatly 
researched field of regenerative medicine and tissue engineering therapies and 
has become an essential part of dentistry. Mesenchymal stem cells are multipotent 
stem cells that can differentiate into many cell types. Dental mesenchymal stem cell 
populations have been identified in dental pulp, human exfoliated deciduous teeth, 
periodontal ligament, dental follicle of third molars, tooth germ of third molars, 
gingiva of periodontium, alveolar bone, and apical papilla. Dental stem cells are the 
most natural, noninvasive source of stem cells that have been identified, and they 
have gained recent attention due to their accessibility and the associated relatively 
low cost of integration into regenerative therapy. Long-term preservation of dental 
stem cells is becoming a popular consideration and mirrors the ideology of banking 
umbilical cord blood. This review outlines the recent progress in the mesenchymal 
stem cells used in dentistry as well as some advancements that are being made in 
preserving dental stem cells for future personalized medicine. The aim of this study 
was to completely and concisely review the current use of adult dental stem cells 
specifically oral sources of stem cells, banking of dental stem cells, and applications 
or uses of dental stem cells specifically in oral regions and in a clinical setting.
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1. Introduction
There exists an association between oral health and overall health throughout 
the lifetime of an individual. Because of this association, advancements are being 
made in dental practice to maintain teeth and orofacial bone as a way to combat 
general decline in oral health. Current common practice includes the use of arti-
ficial materials in dental implant procedures and other prosthodontic therapies. 
While often effective, these methods frequently require costly and invasive proce-
dures and may result in failure or rejection. Recent research has given much atten-
tion to bettering therapeutic treatment and regenerative medicine associated with 
maintaining oral health. At the forefront of this research is investigating the use of 
stem cells in tissue regeneration, specifically in dental practices [1]. The use of stem 
cells in dentistry focuses on making the transition from using artificial materials in 
treatments to using individualized biological materials resulting in greater per-
sonalized medicine. The oral cavity has many locations from which to obtain stem 
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cells, and stem cells can be harvested throughout many stages in an individual’s life. 
Stem cell preservation through banking must be considered as a preventative way to 
obtain he biological materials necessary to make personalized medicine a common 
practice.
Adult stem cells, specifically mesenchymal stem cells (MSCs), can be loosely 
defined as immature multipotent cells that mature and multiply, and turn into 
many and more specific types of cells and tissues through the process of differentia-
tion. The MSCs can be first derived from neural crest cells and pluripotent progeni-
tor cells both of which develop during embryonic and child development [2]. A 
cell must be able to self-replicate and differentiate into two or more cell types to be 
considered MSCs [3]. Stem cells are the greatest source for means of regenerative 
medicine because they are autologous to the native tissue with low tumorigenesis 
risk and unlikely immune rejection [4]. Tooth derived MSCs, from both primary 
and permanent teeth, are of great interest regarding regenerative medicine because 
of how accessible they are due to the minimally invasive means through which these 
stem cells are obtained.
Stem cell use, specifically in dentistry, is on the forefront of research and 
clinical application because there are many sources of stem cells in the oral cavity. 
Treatment of a number of dental, oral, and craniofacial diseases using stem cells is 
currently being explored. Tooth-derived MSCs have great capability to proliferate 
and differentiate into many mesoderm lineages, and their performance aligns with 
MSCs from non-oral origins [5].
Discoveries are continuing to be made regarding which stem cells have the most 
advantageous characteristics for success in allogenic treatment in dental regen-
erative medicine. Dental stem cells come from a number of sources that can be 
obtained at different points throughout an individual’s life. These sources include 
dental pulp [6], human exfoliated deciduous teeth (SHED) [7], periodontal liga-
ment of periodontium [8], dental follicle of third molars [9], tooth germ progenitor 
cells of third molars [10], gingiva of periodontium [11], alveolar bone [12], and 
apical papilla [13–15]. These sources each have varying levels of proliferation and a 
range of differentiation capabilities.
Two types of stem cells are necessary for dental hard tissue regeneration: 
epithelial stem cells, responsible for the formation of enamel, and mesenchymal 
stem cells, responsible for the formation of dentin [16]. While research and clinical 
applications exist regarding the use of MSCs in dentistry, no information is cur-
rently available regarding dental epithelial stem cells [1, 16].
The success of stem cell therapy is exemplified through a process known as stem 
cell banking which includes harvesting, storing, and cryopreserving the cells. Stem 
cell banking highlights the ideology of individually personalized medicine being 
the best preparation for future treatment and is quickly increasing in research and 
clinical attention [17]. Advantages to dental stem cell banking include: (a) safety 
in harvesting, (b) low ethical concerns present compared to that of applications of 
embryonic stem cells [3], (c) noninvasive means of harvesting [7], and (d) autolo-
gous source of stem cells.
2. Background
MSCs are the group of stem cells that are the most heavily researched and com-
monly used in clinical application. Being multipotent, they possess the capability to 
mature and differentiate into multiple mesenchymal tissue lineages: mesodermal, 
ectodermal, and endodermal lineages [18]. MSCs are also characterized by their 
ability to self-renew and proliferate to maintain the source of undifferentiated stem 
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cells. Additionally MSCs have been shown to possess immunomodulatory effects 
including angiogenesis, anti-inflammation, and antiapoptosis [1] showing their 
great potential for use in regenerative medicine. Furthermore, MSCs are associated 
with minimal ethical controversy and can be obtained from many adult tissues in 
the body [19]. The study of human MSCs began with their being identified and 
researched in bone marrow. Through experimentation, bone marrow derived stem 
cells (BM-MSCs) have been found to regenerate certain skeletal tissues including 
bone, cartilage, and adipose and fibrous tissues [20]. While research has shown 
effective use of BM-MSCs in tissue regeneration, the rather invasive measures 
through which these cells must be obtained make BM-MSCs an unlikely candidate 
for expansion and normalization of personalized medical treatments. Scientists 
since have investigated means to obtain and isolate MSCs from other various tissues 
in the body. Some of these include adipose tissue [21], endometrial tissue [22], 
salivary gland [1], umbilical cord [23], synovial membrane and fluid [24], blood 
[25], and oral sources [1]. MSCs from oral sources are among the most easily acces-
sible stem cells and often may be obtained through minimally invasive measures. 
They have also been found to possess similar immunomodulatory characteristics 
as BM-MSCs [26]. Because of their accessibility, researchers continue to investigate 
their clinical applications in regenerative medicine. There are eight identified popu-
lations of MSCs found in teeth and their supporting structures of the oral cavity.
3. Dental pulp stem cells
In 2000 Gronthos et al. were the first to identify MSCs located in the dental pulp 
of teeth [6] that are today known as dental pulp stem cells (DPSC). These cells were 
investigated based on their supposed clonogenic and proliferative characteristics. 
Gronthos et al. suggested that DPSC have the progenitors required to amount 
similar cellular characteristics to those of BM-MSCs [6], a population of stem 
cells that is better understood. The research focused on comparing DPSC forming 
odontoblasts and BM-MSCs forming osteoblasts, specifically investigating if the 
DPSC possess the same proliferation and differentiation capabilities as BM-MSCs 
in both in vitro studies and in vivo by ex vivo transplantation into immunocom-
promised mice. Experimentation of DPSC mirrored the previously established 
biological pathways of BM-MSCs. Odontoblasts are responsible for the formation 
of dentin and are suspected to arise from the dental pulp, but little information is 
known about the specific cell population that gives rise to the odontoblasts in the 
dental pulp cavity [6] and what biological scaffold is most effective in aiding in the 
production of odontoblasts.
Gronthos et al. obtained pulp tissue from third molars of individuals aged 19–29. 
In vitro experimentation on differentiation potential of DPSC showed no forma-
tion of adipocytes, while BM-MSCs showed formation of adipocytes. Both cell 
populations were found to be clonogenic during in vitro manipulation. The DPSC 
were found to have a high proliferation capacity and proliferated more than the 
BM-MSCs [6]. BM-MSCs display bone formation on a hydroxyapatite/tricalcium 
phosphate (HA-TCP) powder, thus DPSC were observed in conjunction with 
HA-TCP powder to investigate if the DPSC would display a similar response as the 
BM-MSCs [6]. In vivo transplantation of DPSC resulted in odontoblast-like cells 
of human origin and contained the dentin-specific protein necessary to generate 
dentin [6]. This suggests the HA-TCP powder was conducive to the DPSC like the 
BM-MSCs.
Gronthos et al. concluded that the DPSC are able to be considered a source of 
stem cells because of their profound regeneration, differentiation, and proliferation 
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capabilities. DPSC may be harvested from one pulp cavity and applied to dentin 
regeneration in many teeth [6]. Granthos et al. call for future research to investigate 
the biological scaffold that will amount to the most dentin regeneration associated 
with in vivo transplantation of DPSC.
4. Stem cells from human exfoliated deciduous teeth
In 2003 Miura et al. identified human exfoliated deciduous teeth (SHED) as a 
profound source of MSCs [7] to be considered for use in autologous regenerative 
therapies. The cells were researched using prior methodology of umbilical cord 
derived stem cells and investigated specifically regarding the prior knowledge and 
research pertaining to umbilical cord derived stem cells. The study focused on ex 
vivo success through in vivo transplantation. An advantage of SHED as a source of 
stem cells is that they are easily obtained from an individual at a relatively young 
age. SHED are found in the dental pulp that is left in deciduous teeth that are lost 
and replaced with adult permanent teeth during adolescence in an individual’s 
lifetime. This makes SHED an ideal candidate for preservation through stem cell 
banking. The cells must be able to be preserved for use at a later time in the indi-
vidual’s life if they are to be considered a viable source of stem cells for regenerative 
medicine and treatment. Similar to DPSC, SHED provide a relatively large source of 
stem cells as cells harvested from one pulp cavity may be also used in regenerative 
treatment for many other teeth of the individual.
Miura et al. obtained pulp tissue from human exfoliated deciduous incisors 
from 7 to 8 year old individuals [7]. The researchers suggest SHED may be originat-
ing from a perivascular environment [7] due to their origin and association with 
vasculature in the dental pulp. The SHED were investigated in both in vitro studies 
and in vivo by ex vivo transplantation into tissues of immunocompromised mice. 
Single cells were isolated and allowed to proliferate to form populations of cells as 
a way to measure their characteristic clonogenicity. The study also showed that the 
SHED have greater in vitro proliferation capabilities regarding formation of cell 
populations as compared to both BM-MSCs and DPSC [7]. The cell populations 
were then induced to differentiate, and were successful in differentiating, into the 
following cell types in vitro: odontoblast-like cells, adipocytes, and neuronal cells 
[7]. Furthermore, the cells differentiated into odontoblast-like cells on HA-TCP 
powder and were able to survive after in vivo transplantation.
The same MSCs markers as BM-MSCs and DPSC have displayed were observed 
on SHED suggesting similar differentiation capabilities among the various sources 
of stem cells. However, SHED were found to differentiate into odontoblasts in vivo 
but were not successful in differentiating into dentin pulp-like complex like DPSC 
have been shown to do [7]. This suggests SHED possessing alternative differentia-
tion capabilities or means of differentiating than those understood to be true of 
DPSC. Additionally, while the SHED were successful in producing odontoblast-like 
cells, SHED were unable to differentiate to produce osteoblasts. The cells were, 
however, able to induce varying degrees of bone formation in nearby host cells in 
vivo after transplantation. Miura et al. proposed the SHED may play a role in bone 
formation around permanent adult teeth as the deciduous teeth are exfoliated [7].
Miura et al. concluded that SHED are in fact a viable source of multipotent stem 
cells and have great potential in playing a role in regenerative medicine [7]. The 
researchers suggest the differences between SHED and DPSC may be attributed to 
the developmental differences between adolescent deciduous teeth that are meant 
to be exfoliated and the development of permanent adult teeth that are made to 
survive an individual’s lifetime. Miura et al. call for future research to investigate 
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the purpose of SHED in adolescent deciduous pulp cavities, as understanding their 
purpose may lead to greater understanding of SHED and thus greater application of 
SHED in regenerative medicine.
5. Stem cells from periodontal ligament of periodontium
The periodontal ligament (PDL) was found by Seo et al. to be a source of 
multipotent stem cells capable of playing a role in regenerating periodontal tissue 
[8]. The cells of the PDL were investigated based on the known differentiation 
properties of the PDL, and this information was then used to obtain evidence 
that the PDL obtains stem cells and may be used for generation of cementum and 
new PDL specifically in vivo. Additionally, cellular markers and other multipotent 
determining properties of periodontal ligament stem cells (PDLSC) were com-
pared to those of both DPSC and BM-MSCs. There exist other populations of cells 
that are capable of regeneration and possess many osteoblast-like properties, but 
no prior evidence of a stem cell population had been observed in the PDL [8].
Seo et al. extracted third molars from 19 to 29 year old humans, and the cells 
from the PDL were isolated and induced to proliferate in vitro [8]. Interestingly, 
PDLSC were found to accumulate less calcium than DPSC [8]. Through in vitro 
studies, PDLSC were determined to have adipogenesis capabilities as well as 
proliferate into cementoblast and odontoblast-like cells. The ex vivo colonies were 
transplanted in vivo to immunocompromised mice through in vivo transplantation, 
specifically to the periodontal area of the mice. PDLSC developed cementum-like 
tissue different from tissues generated from BM-MSCs and DPSC suggesting a 
difference in differentiation capabilities of the three cell groups [8]. The PDLSC do, 
however, obtain the same cellular markers expressed by BM-MSCs and DPSC that 
suggest a potential perivascular origin [8]. The PDLSC were also able to interact 
physiologically with the host collagen fibers suggesting they possess the capability 
to differentiate into cells to produce collagen fibers as well [8]. The in vivo integra-
tion of PDLSC into the periodontal area of which they were transplanted suggests 
great potential for future application of periodontal tissue regeneration using 
PDLSC despite their failure to attach to the bone of the teeth [8].
Seo et al. conclude that PDL is a viable source for obtaining multipotent mesen-
chymal stem cells and is consistent with the clonogenic, proliferative, and differen-
tiating characteristic of mesenchymal stem cells from oral sources [8]. This was also 
confirmed by Kawanabe et al. [27] and Menicanin et al. who confirmed the stem 
cell properties of PDLSC and further evaluated the post-transplant self-renewal 
potential of PDLSC [28]. Menicanin et al. further concluded that PDLSC possess 
significant capability to self-renew and regenerate periodontal tissue [28]. Onizuke 
et al. confirmed PDL as a source of stem cells and further analyzed the applica-
tion of cell sheet engineer technologies in forming bioresorbable scaffolds to best 
support integration of the PDLSC for clinical applications [29]. Seo et al. call for 
future investigation of the cellular markers specific to PDLSC different from those 
expressed by BM-MSCs and DPSC. Additionally they conclude future research 
should analyze PDLSC and their PDL tissue regeneration on a larger quantity of test 
animals and a larger size test subject population [8].
6. Stem cells from dental follicle of third molars
Stem cells obtained from the dental follicle of third molars have also been deter-
mined to be a source of oral derived MSCs valuable in contributing to regenerative 
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medicine [9]. The dental follicle was investigated based on its supposed capacity 
to differentiate into cementoblasts, osteoblasts, and periodontal ligament cells as 
well as its ease in accessibility from extracted teeth. Dental follicle cells possess the 
progenitors for osteoblasts that are responsible for aiding the development of many 
tooth related structures during growth and eruption of teeth and development of 
alveolar bone [9]. Findings from Gronthos et al. [5] research of DPSC were applied 
to the study of DFSC to identify if DPSC possess similar proliferation and differen-
tiation capabilities.
Morsczeck et al. studied human dental follicle cells of extracted third molars [9]. 
The cells were isolated and induced to differentiate in both in vitro experimenta-
tion and ex vivo through in vivo transplantation using immunocompromised mice. 
A HA-TCP powder was included to induce uptake of the cells into the mice. It was 
found that DFSC behave similarly to the cells of the periodontium and are capable 
of regenerating cells types associated with the periodontium including alveolar 
bone, cementum, and periodontal ligament [9]. Morsczeck et al. concluded that 
DFMSC can play a role in bone tissue engineering and possess the necessary cellular 
markers to be considered stem cells [9].
A similar study was conducted by Park et al. that focused on comparing human 
skin derived MSCs, BM-MSCs, and DFSC [30]. Findings confirmed that DFSC have 
the capacity to differentiate into osteocytes, chondrocytes, and adipocytes in vitro 
[30]. Successful in vivo experimentation suggested that although the DFSC inves-
tigated possess MSC-like cellular markers similar to those of DPSC and BM-MSCs, 
further research should be conducted regarding the multipotency of the cells [30]. 
Osteogenic potential was however observed in both in vitro and in vivo cell popula-
tions of DFSC [30].
7. Tooth germ progenitor cells from third molars
In 2007 Ikeda et al. identified stem cells found in the tooth germ of developing 
third molars and termed them tooth germ progenitor cells [10]. The tooth germ 
includes many tooth-related tissues in the oral cavity, but more specifically refers 
to the developmental stage of these tissues [31]. The purpose of the study was to 
research the morphology, proliferation, and multipotency of the TGPC which were 
studied based on their ability to turn into hepatocytes mirroring the differentiation 
capabilities of BM-MSCs [32], but different from previously discussed orally-
derived MSCs. The researchers focused on investigating TGPC specifically regard-
ing their use in treatment of liver diseases with the goal of restoring liver function 
caused by liver disease through the use of stem cells as an alternative to drug 
therapy [10]. TGPC obtained at a young age from the tooth germ of developing 
third molars are associated with few ethical concerns due to their routine extraction 
that normally results in disposal making them a great source for potential harvest-
ing of stem cells.
The cell populations were tested both in vitro and ex vivo through in vivo trans-
plantation into immunocompromised mice with HA-TCP use in transplantation 
[10]. In vitro the cells were found to maintain their morphology and clonogenic 
properties through the isolation and cell population formation and showed the abil-
ity to differentiate into cells of three germ layers [10]. The cells possessed the cellu-
lar markers specific to mesenchymal cells, and transcription factors were observed 
suggesting pluripotency and confirming their stem cell characteristics [10]. The 
mesenchymal character of these cells was also confirmed by Yalvac et al in 2010 as 
well as their ability to differentiate into progenitor cells with adipocyte, neural, and 
osteogenic characteristics [31]. Yalvac and team also observed that TGPC expressed 
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the cellular markers indicating stem cell character at a significantly higher level 
compared to DPSC [31]. In vitro cells displayed characteristics of osteoblasts, dif-
ferentiated into neuronal cells and hepatocyte-like cells sharing characteristics of 
functional hepatocytes [10]. The Ikeda et al. were the first to show that the neural 
crest derived cells can differentiate into cells from the endoderm lineage [10]. After 
transplantation however, the in vivo cells showed great proliferation and indicated 
bone formation through the presence of osteocytes instead of only osteoblasts [10].
Ikeda et al. concluded that TGPC are able to play an important role in regenera-
tive medicine specifically related to the development of hepatocytes. Successful 
cloning and proliferation in both in vivo and in vitro studies confirmed the stem cell 
qualities of TGPC on treatment of liver disease. The team calls for future research to 
be conducted investigating the capacity to which the application of TGPC differen-
tiating into hepatocytes may be applied to regenerative medicine regarding other 
tissues [10], including tissues of the oral cavity.
8. Gingiva-derived mesenchymal stem cells
In 2009, Zhang et al. identified human gingival tissue as a source of MSCs to be 
considered for tissue regeneration and treatment [11]. The GMSC were investigated 
based on their abundance, accessibility, and tendency to be discarded as waste 
from surgical procedures. The focus of the study was to determine to what extent 
the GMSC are able to regenerate tissue and display associated anti-inflammatory 
characteristics, specifically in treatment of colitis [11].
The study was conducted using both in vitro and in vivo by ex vivo transplan-
tation of human gingiva cells collected from the periodontium. The cells were 
isolated, then showed higher proliferation capacity compared to BM-MSCs [11]. 
In vitro the GMSC displayed successful differentiation into adipocytes and osteo-
blasts of the mesoderm lineage as well as endodermal and neural ectodermal cells 
suggesting stem cell character [11]. Additionally the GMSC were shown to possess 
the cellular markers specific to stem cells and phenotype associated with mesenchy-
mal progenitor cells [11] further confirming their stem cell character.
The GMSC were transplanted using a HA-TCP carrier to mice infected with 
experimentally induced colitis. In vivo the cells were found to reduce disease 
severity and significantly reverse inflammation in the mice. Interestingly, the cells 
formed connective-like tissue instead of the expected osteoblast formation sug-
gesting these cells may be useful in tissue regeneration [11]. Zhang et al. call for 
future research to investigate if osteogenesis may be induced in vivo with the aid of 
a different transplant carrier [11].
More recent research has shown GMSC ability to differentiate into osteogenic 
cells in vivo [33]. Yang et al. compared the capacity of both GMSC and PDLSC 
to periodontal disease treatment [33]. GMSC exhibit enhanced ability upon 
transplantation to combat inflammation compared to PDLSC regarding in vivo 
osteogenesis which is explained by the unique characteristics associated with the 
gingival tissue regarding its immunoregulatory function and expedited healing 
[33]. Yang et al. call for future research on determining the best feasible methods 
to incorporate the use of GMSC in therapeutic treatment of periodontal disease 
in tissue repair and regeneration in a clinical setting [33]. Tomar et al. compared 
GMSC and BM-MSCs specifically regarding if they may be considered a viable and 
sustainable source of stem cells to be used in regenerative medicine in a clinical 
setting [34]. GMSC compared to BM-MSCs were found to provide a more stable 
source of stem cells regarding ability to proliferate and retain morphology in a 
long-term culture setting as is necessary for clinical application [34]. This was also 
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confirmed by Sun et al. [35] and Tomasello et al. [36] who agree GMSC should be 
considered as a source for generation of bone in regenerative medicine.
Continued research on GMSC examine the advantages the cells offer to cuta-
neous wound healing [37], tendon regeneration [38], as well as regeneration of 
peripheral nerve defects in vivo [39]. The wide array of applications and character-
istics these stem cells possess deem them potentially useful in tissue regeneration 
and treatment specifically in the oral region and in a clinical setting.
9. Alveolar bone-derived mesenchymal stem cells
In 2005 Matsubara et al. identified the alveolar bone of the jaw as a viable 
source for stem cells to be used in autologous bone regeneration [12]. An advan-
tage of ABMSC as a source of stem cells is that they are easily obtained from an 
individual during dental implant surgery or extraction of third molars as the 
alveolar bone is often exposed or accessible during both of these surgical proce-
dures. ABMSC are often less painful to obtain compared to BM-MSCs from other 
bones in the body [12].
Matsubara et al. harvested human alveolar bone during normal third molar 
extractions [12]. The cells were researched using prior methodology of BM-MSCs 
and investigated specifically regarding the prior knowledge and research pertain-
ing to BM-MSCs. Single cells were isolated and allowed to proliferate to form 
populations of cells as a way to measure their characteristic clonogenicity. The 
study focused on ex vivo success through in vivo transplantation into immuno-
compromised mice. The researchers compared the ABMSC to BM-MSCs from the 
iliac bone [12] regarding their proliferation and differentiation capacities. Upon 
examination in vitro, ABMSC were found to possess similar stem cell character and 
cellular markers as BM-MSCs regarding osteogenic proliferation, but displayed 
significantly less adipocyte and chondrocyte potential compared to BM-MSCs [12]. 
Furthermore, the cells differentiated into odontoblast-like cells on a calcium phos-
phate scaffold and were able to survive after in vivo transplantation. Additionally, 
an association between age of patient and proliferation was observed showing a 
decline in proliferation with increased age of individual from which the cells were 
obtained. This decline was noticeably larger than that of the MSCs from the iliac 
bone being studied. Matsubara et al. acknowledge the varying research regarding 
this association and suggest banking of the stem cells obtained from extracted third 
molars of individuals at a relatively young age suggests the greatest potential for 
application in a clinical setting [12].
Matsubara et al. concluded that ABMSC are in fact a viable source of multipo-
tent stem cells and have great potential in playing a role in regenerative medicine, 
specifically regarding bone regeneration. They call for future investigation to deter-
mine if a different transport medium might increase the potential of ABMSC to 
differentiate into adipocytes and chondrocytes. Because of the strong osteogenesis 
potential of ABMSC, they are interested in determining the best clinical application 
of ABMSC in repairing bone in treatment of periodontal disease [12].
Another in vivo study focused on using stem cell sheets made from ABMSC 
as a non-scaffold approach for bone regeneration in the calvaria bone of rabbits. 
Liu et al. observed greater osteogenic differentiation in ABMSC than in long bone 
MSCs [40] showing greater mineral deposition and cellular markers indicating 
osteogenesis. However, similar research by Pettersson et al. showed that ABMSC 
and BM-MSCs display no significant difference in their ability to differentiate into 
osteogenic cells [41]. Research is unclear regarding comparing the differentiation 
ability of ABMSC and BM-MSCs, however research concludes that ABMSC are a 
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potential source of MSCs to be considered for regenerative treatment in craniofacial 
defects in a clinical setting [40–42].
10. Stem cells from apical papilla
In 2006 Sonoyama et al. identified apical papilla from the root of human teeth 
as a novel source of mesenchymal stem cells to be considered for oral tissue regen-
eration [15]. The goal of the study was twofold: to confirm tooth apical papilla as 
a viable source of stem cells and to explore the combination of SCAP and PDLSC 
in regeneration of a root periodontal structure and associated tissues necessary to 
support an artificial crown [15]. A healthy and stable root is necessary to recover 
and maintain a functional tooth, and SCAP are thought to aid in regeneration of 
roots and surrounding tissues of teeth. SCAP provide a unique source of stem cells 
because they may be harvested from one source of apical papilla and applied to 
tissue regeneration in many surrounding teeth due to their great proliferation [15].
SCAP were collected and isolated from human apical papilla from normal 
extractions of third molars and allowed to proliferate to form cell populations for in 
vitro studies. The cells displayed cellular markers indicative of MSC character and 
were induced to successfully differentiate into osteoblasts and adipocytes [15]. Cells 
were then transplanted into immunocompromised mice with a HA-TCP carrier for 
further in vivo testing. The cells were able to generate both dentin and connective 
tissue in the in vivo model suggesting SCAP are a unique group of stem cells with 
different differentiation capacity than most dental derived stem cells [15]. In fact, 
SCAP showed greater differentiation into dentin than was expressed by DPSC [15].
An additional in vivo study was conducted using SCAP and PDLSC from swine 
followed by transplantation into immunocompromised mice. There exist simi-
larities between human dental tissues and those found in swine thus conclusion 
can be made regarding human regenerative medicine based on the success of the 
tissue from swine [15]. Sonoyama et al. used SCAP and PSLSC from the swine and 
observed formation of cementum on the scaffold. Formation of both dentin and 
PDL are necessary to regenerate a viable root periodontal structure capable of sup-
porting a tooth.
Sonoyama et al. propose that this is a viable method for functional restoration 
of teeth and supporting structures in a clinical setting [15]. They call for future 
research to be conducted regarding the immunogenicity of the cells and suggest 
that SCAP may be an ideal candidate for stem cell banking [15]. Current research 
focuses on identifying the precise biomaterials that make up the environment in 
which SCAP best contributes to tissue regeneration such as oxygen level [43] and 
ideal makeup of a transplant carrier [44, 45].
11. Current clinical applications
The current advancements and the recognition of the use of stem cells in 
regenerative medicine has resulted in human clinical trials. Various human clinical 
trials applying stem cells from different sources in treatment of oral conditions are 
presented below. Additionally, there continue to be preclinical studies aiming to 
perfect the transition from autologous source to implementation of stem cells prior 
to the application of research in human clinical trials. These preclinical studies often 
aim to determine which scaffolding methods and materials are the most promising 
to ensure effectiveness of stem cell application with minimal senescence [46]. The 
studies also attempt to identify the specific microenvironment conditions in which 
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the cells are both taken from and placed for regenerative treatment and how it 
will impact the potential and effectiveness of the proliferation and differentiation 
capacities of the cells [47].
Nakashima et al. performed a pilot clinical study with five patients in which they 
analyzed the capacity of DPSC to regenerate dental pulp in patients with irrevers-
ible pulpitis [48]. They observed great success in all of their patients regarding 
regeneration of pulp tissue in the root canals as well as dentin formation in over 
half of the participants [48]. Although their endodontic study was successful, 
Nakashima and team call for larger clinical trials to be performed before imple-
mentation of their practices [48]. Xuan et al. performed a larger human clinical 
study with 20 patients expressing regeneration of pulp tissue to teeth that had 
experienced necrosis resulting from trauma [49]. The tissue regeneration included 
blood vessel and nerve regeneration and successful regeneration was still observed 
24 months post stem cell implementation [49]. Raddall et al. further studied the 
specific scaffolding materials and methods for implementation of DPSC in end-
odontic regenerative treatment of the tooth root [50]. Their research both identifies 
successes and presents challenges with the scaffolds investigated. Their research, 
however, gives an example of how studies today are directed towards perfecting the 
methodology of implementation of stem cell therapies.
DPSC have also been successful in regenerating bone lost from periodontal 
disease [51–53]. Ferrarotti et al. observed a significant decrease in periodontal 
disease and an increase formation of bone in the intrabony defects when compared 
to the control patients of their study [51]. Hernández-monjaraz et al. observed 
decreased tooth mobility, a significant decrease in periodontal disease, and an 
increase in bone mineral density six months post operating [52]. Aimetti et al. also 
observed complete bone regeneration of intrabony defects on the mandibular bone 
in their study on a patient with chronic periodontitis [53]. All three studies con-
clude that the application of DPSC to bone periodontal disease shows significant 
improvement in a clinical setting with no observed adverse effects. Barbier et al., 
however, observed no significant difference in mandibular post extraction socket 
healing resulting from use of DPSC [54]. Also in this study, bone density nor 
interdental septum height were found to be significantly increased by the addition 
of DPSC [54].
Additionally, PDLSC have been used to treat periodontal disease in the regen-
eration of periodontal tissues. In a recent study by Iwata et al., bone regeneration 
decreased probing depth and increased radiographic bone depth in 10 patients six 
months after treatment [55]. The PDLSC were introduced using cell sheets into 
third molar extraction sites. Iwata et al. recognize PDLSC as a promising source for 
periodontal disease treatment and bone regeneration [55].
12. Discussion of stem cell banking
Stem cell banking may be loosely defined as the collection, isolation, and pres-
ervation of stem cells in preparation for use in regenerative treatment and therapy. 
The instance in which the cells are available for harvest might not align with when 
the cells are needed; thus the cells must be stored and preserved in a manner that 
will maintain the functionality of the cells over a potentially long period of time. 
The process is unique because it provides the means for individualized autolo-
gous medicine that can be implemented throughout an individual’s lifetime [17]. 
Personalized advancements in medicine have the goal of increasing tolerance of 
the immune system and low rejection by host due to the host and the donor being 
11
Dental Stem Cell Banking and Applications of Dental Stem Cells for Regenerative Medicine
DOI: http://dx.doi.org/10.5772/intechopen.95407
the same individual. Specifically, dental stem cell banking utilizes the stem cells 
obtained from the oral region, and dental professionals, especially oral surgeons, 
are responsible for the collection of the cells. Dental stem cell banks were created in 
response to the identification of the oral region as a source of stem cells and current 
research investigates the best means of collecting, isolating, and preserving the cells 
so that the full potential of use of these cells may be reached in the advancement of 
personalized medicine.
The various oral sources of stem cells, as previously discussed, can be harvested 
during tooth extractions, the naturally occurring exfoliation of deciduous teeth, or 
through other minimally invasive surgeries. An advantage of utilizing orally derived 
stem cells is that there are fewer ethical concerns associated with their harvesting 
than with obtaining stem cells from embryological sources [17]. Additionally, the 
harvesting of DMSC is often simple and painless through a less invasive manner 
than stem cells harvested from other regions of the body as they are often a byprod-
uct of a surgical procedure and would otherwise be discarded as waste. Dental stem 
cell banking, specifically using SHED, was found to be more cost efficient than 
banking stem cells obtained from cord blood [56]. If stem cells from cord blood 
were not obtained, stem cells from oral sources offer more opportunities in an 
individual’s life to harvest and bank stem cells [56]. Stem cell banking is a proac-
tive form of personalized medicine as the individual chooses to bank their cells in 
preparation for their future medical needs.
Current research regarding the banking of stem cells focuses on determining the 
specific conditions for optimal collection, isolation, and preservation of dental stem 
cells. By identifying the specific condition in which to harvest and store the cells, 
the proliferation and differentiation capacities of the stem cells can be maintained.
13. Collection
Stem cell banking begins in the dental chair with the collection of the cells 
during a scheduled extraction or routine eruption of the tooth. The dental profes-
sional assisting in the process works with the stem cell bank to decide regarding 
the specificities of harvesting the cell and initial processing steps. Dental stem 
cell banks currently exist in Japan, the United States, India, the United Kingdom, 
Germany, Singapore, Mexico, India and Norway. Dental stem cell bank information 




Store-a-Tooth by Provia Laboratories, LLC, USA (http://www.store-a-
tooth.com/).
National Dental Pulp Library, LLC (https://ndpl.net/).
Tooth Bank, USA (https://www.toothbank.com/).
It is important that the tooth from which the cells are collected is a normal 
healthy tooth with little to no decay due to pulpitis. Tsai et al. investigated the 
impact of dental pulpitis on the effectiveness of stem cell banking and found it to 
be ineffective overall [57]. A slower colonization process and increased proinflam-
matory cytokines were observed on the cells infected with pulpitis making then an 
unideal candidate for stem cell banking [57].
The cells are immediately placed in a container of sterile saline solution to main-
tain the vitality of the cells and to keep them from drying out during transport. 
The time between when the cells are collected and when the cells are processed is 
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an important factor to determine the usefulness of the cells as the tissue may begin 
to degrade [58]. Perry et al. studied the impact of time between collection and 
processing and was able to obtain cells for culturing up to 120 hours after extraction 
[59]. This suggests that immediate processing post extraction is not a crucial factor 
necessary to effectively bank stem cells.
Perry et al. also investigated the most effective collection transport medium to 
be used in the transition from the dental office to the lab where the cells are isolated. 
No notable difference was found between using PBS compared to HTS. PBS is the 
cheapest and most accessible medium to store in a dental office, however, there 
exist other transport media that can be considered for use as well. Slight alterations 
in the numbers of cells that are obtained for processing from the different medias 
are negligible because as the cells are processed, enough cells will be proliferated in 
the growing cell cultures [59].
14. Isolation
Isolation refers to the processing of the cells in preparation for preservation 
by the stem cell bank that is preserving them. As previously mentioned, isolation 
of cells is possible up to 5 days after the tooth containing the cells is extracted or 
removed from its source [59]. The pulp from the harvested tooth is disinfected, 
and the cells are isolated and cultured in MSC media. The focus of current 
research is identifying the optimal conditions in which the cells are allowed to 
proliferate and colonize. Factors to be taken into consideration are the process 
through which the cells are isolated, the extent to which the cells are digested, 
the means of cellular attachment during culturing, and the media, serum, and 
supplements that are used to enhance cellular growth and function during the 
culturing process. Perry et al. identified proper sterilization of the harvested teeth 
as the most important aspect of forming uninfected and sterile cell cultures [59]. 
Additionally, they investigated the efficiency of the cells establishing cell cultures 
after being isolated from the harvested teeth. Cell colonies were present and dis-
played viable cells after 14 days of isolation [59]. Throughout the study, the stem 
cell populations were tested to confirm their MSC-like character. The cells pos-
sessed the necessary cellular markers characteristic of MSCs as well as displayed 
the ability to differentiate into osteogenic, adipogenic, and chondrogenic cells as 
is characteristic of MSCs [59].
15.  Preservation - cryopreservation and magnetic field programmed 
freezing
Cryopreservation is the process of cooling cells to an eventual temperature 
below 150°C by liquid nitrogen vapor. The cells must freeze carefully and quickly 
as to not form ice crystals which would result in cell death [60]. This is the main 
cellular damage that a cell may experience as a result of cryopreservation as well as 
mechanical stress from ice formed outside of the cell [61]. A cryoprotective agent 
(CPA) can be used in the vitrification process to maintain cell functionality during 
preservation, but the cryoprotectants are often harmful to the cells or even can 
cause cell death [62]. Through cryopreservation, cells are able to maintain their 
cellular markers, gene expression, and differentiation potential [59]. Perry et al. 
determined this through the comparison of DPSC before and after cryopreservation 
[59]. However, some changes in proliferation capacity are observed before and after 
cryopreservation [63–65].
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In 2010 Kaku et al. from Hiroshima University developed an alternative 
method for cryopreservation using a magnetic field programmed freezer instead 
of the established cryopreservation method. The novel method of preserva-
tion was created to combat both ice formation inside and outside of the cell as 
well as the toxicity associated with necessary levels of CPA [61]. This system 
of preservation is referred to as the cells alive system (CAS) and was adapted 
from an existing freezing methodology implemented in the food industry [61]. 
The CAS applies a weak magnetic field to the sample which lowers the freezing 
point. Kaku et al. were able to determine the optimal hold time and plunging 
temperature necessary to freeze the cells without inducing obstruction to the cel-
lular membrane. Proliferation as well as differentiation capacity were observed 
for the cells to ensure they maintained their MSC-like character throughout 
the study [61]. Kaku et al. specifically investigated the magnetic field freezing 
using PDLSC and found that they could proliferate equally as the teeth that were 
observed immediately post extraction [61]. Another study by Lee et al. observed 
similar results upon investigation of DPSC compared to cells from teeth that 
were not preserved [66].
Interestingly, viable stem cells have not only been obtained from post pres-
ervation isolated cell populations but also from teeth that were preserved intact 
[59, 65, 67]. This confirms that immediate processing post extraction is not a crucial 
factor necessary to effectively bank stem cells which would in turn result in lowered 
costs associated with banking stem cells as the processing of the cells is the most 
costly part of the process [58, 59, 63].
16. Conclusion
With the discovery and research of dental stem cells come great opportunities 
to utilize these cells in regenerative medicine and dental tissue repair. The aspects 
of each source of stem cells must be analyzed so that the best candidate for stem 
cell banking and the specific regenerative treatment may be used in personalized 
medicine. The eight sources of stem cells and their ability to successfully aid in 
regeneration of tissues have been analyzed: human exfoliated deciduous teeth, 
dental pulp stem cells, periodontal ligament stem cells, dental follicle stem cells, 
tooth germ progenitor cells, gingival-derived mesenchymal stem cells, alveolar 
bone mesenchymal stem cells, and stem cells from the apical papilla. The relatively 
recent developments in stem cell biology make banking dental stem cells a feasible 
option for regeneration of tissues and other oral structures. As with any new 
developments in research, however, there exist certain limitations associated with 
achieving a consistent application in a clinical setting. Despite the many advance-
ments that have been made in the field, the cellular conditions in which the stem 
cells may be collected, isolated, and preserved must be improved and perfected 
before clinical application is regularly implemented. The viability and stability of 
the preserved stem cells must be considered further so that the preservation efforts 
do not result in loss. Appropriate long term double-blind randomized clinical trials 
must be perfected before stem cell therapy may become a normalcy in a clinical 
setting. Additionally, current stem cell research is successful animal models but 
must be further applied to human models before clinical application may occur. 
The opportunity for immune rejection exists, but as is in the case with stem cells, 
immune rejection is limited due to the autologous nature of the cells. With contin-
ued research and developments in the field of stem cell biology, the dental stem 
cells support the continued development and betterment of the stem cell banking 
industry.
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Abbreviations
MSCs mesenchymal stem cells
SHED stem cells from human exfoliated deciduous teeth
DPSC dental pulp stem cells
PDL periodontal ligament
PDLSC periodontal ligament stem cells
DFSC dental follicle stem cells
TGPC tooth germ progenitor cells
GMSC gingival-derived mesenchymal stem cells
ABMSC alveolar bone mesenchymal stem cells
SCAP stem cells from the apical papilla
BM-MSCs bone marrow derived mesenchymal stem cells
DMSC dental-derived mesenchymal stem cells
HA-TCP hydroxyapatite/tricalcium phosphate
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